Skip to content

Carbon 11 labeling of the psychoactive drug o-methyl-bufotenine and its distribution in the animal organism.

G Berger, M Mazière, C Marazano, D Comar

European journal of nuclear medicine April 1, 1978 DOI: 10.1007/BF00251632 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical study Peer reviewed
Population Mice and rabbits
Intervention O-methyl-[11C]bufotenine
Citations 20
Key points O-methyl-[11C]bufotenine can be synthesized with high purity and specific radioactivity, accumulates in brain and other organs, and may be useful for detecting serotonin receptors in vivo.

Abstract

A methylated derivative of serotonin, O-methyl-bufotenine has been labeled with 11C on the two methyl groups of the amine function. In order to avoid the cyclization which occurs during the Eschweiler-Clarke synthesis, we adopted a milder methylation procedure, based on Borch's method using [11C]formaldehyde and sodium cyanoborohydride. Several tens of millicuries of injectable product could be obtained in 50 min in a perfectly pure state and having a specific radioactivity of 50 to 100 mCi/mumol. The distribution study of O-methyl-bufotenine in the mouse and rabbit showed an accumulation of significant quantities of the compound in the brain, kidneys, lungs and liver. The study of the rapid kinetics of this hallucinogenic molecule is compatible with labeling by 11C, having a period of 20 min. The use of O-methyl-[11C]bufotenine to detect serotonin receptors in vivo in mental diseases, is considered.

Citations in the library

Explore topics